Dasom (Caroline) Lee, MD, is a fellow in the Hematology and Medical Oncology Fellowship Program at Stanford Medicine, Stanford Health Care.

Dr Lee on Real-World Early Outcomes With Second-Line Axi-Cel for R/R LBCL

Dasom (Caroline) Lee, MD, Hematology and Medical Oncology Fellowship Program, Stanford Medicine, Stanford Health Care, discusses real-world early outcomes of treatment with second-line axicabtagene ciloleucel (axi-cel; Yescarta) in relapsed/refractory large B-cell lymphoma. Lee and colleagues shared these results in a presentation at the 

OncLive TV

® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers. 

Non-Hodgkin Lymphoma

The OncLive Non-Hodgkin Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on various types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in non-Hodgkin lymphoma.

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


ASH Annual Meeting and Exposition

Dasom (Caroline) Lee, MD, discusses real-world early outcomes of treatment with second-line axi-cel in relapsed/refractory large B-cell lymphoma.